CRISPR-Cas9 Milestones:The First In Vivo Clinical Trial Is Now Underway

BioAgilytix in the News

Pharma's Almanac
December 6, 2019

CRISPR-Cas9 Milestones:The First In Vivo Clinical Trial Is Now Underway

In a contributed article published by Pharma’s Almanac, Dr. Lydia Michaut of BioAgilytix discusses CRISPR-Cas9 genome editing technology to understand its promising benefits and the potential challenges of anti-Cas9 immunity…

Read More

Contract Pharma
November 27, 2019

Immunogenicity Assessment of Gene Therapy Compounds

In an Expert Opinion article published by Contract Pharma, PD Dr. Arno Kromminga of BioAgilytix discusses testing challenges and evolving trends in gene therapy.

Read More

November 11, 2019

Behind the deal: Why a Triangle company is buying its competitor in Cambridge

The Triangle Business Journal covers BioAgilytix’s recent acquisition of Cambridge Biomedical in the Cambridge area of Massachusetts, a known hotbed of biotech innovation.

Read More

Contract Pharma
November 6, 2019

BioAgilytix Acquires Cambridge Biomedical

Contract Pharma covers BioAgilytix’s recent acquisition of Cambridge Biomedical, a CRO specializing in large molecule bioanalysis based in the biotech hub of Boston, MA.

Read More

35 years of NC Biotech
November 5, 2019

Triangle-based BioAgilytix Acquires Cambridge CRO, Plans Hiring, More Acquisitions

North Carolina Biotechnology Center covers BioAgilytix’s recent acquisition of Cambridge Biomedical in the world’s major biotech center, as well as its plans for future hiring and acquisitions.

Read More

WRALtechwire
November 4, 2019

Durham-based BioAgilytix acquires Massachusetts biomedical firm

The WRAL TechWire covers BioAgilytix’s recent acquisition of Massachusetts-based Cambridge Biomedical, and how it plans to unite two science-led teams to expand its footprint in this area of biotech innovation.

Read More

October 14, 2019

TBJ reveals the 2019 Fast 50 Awards winners

The Triangle Business Journal is unveiling the 2019 Fast 50 Award winners (BioAgilytix featured).

Read More

September 25, 2019

Webinar Q&A follow up – exploratory biomarker testing: to qualify or validate the assay?

Afshin Safavi, PhD (Founder and Board Member, BioAgilytix, NC, USA) share his responses to the questions posed by our audience during the live webinar event, “Exploratory biomarker testing: to qualify…

Read More